S&P 500   3,926.63 (+1.17%)
DOW   31,974.10 (+1.38%)
QQQ   323.57 (+0.65%)
AAPL   124.79 (-0.85%)
MSFT   234.52 (+0.54%)
FB   264.56 (-0.49%)
GOOGL   2,081.20 (+1.02%)
AMZN   3,146.46 (-1.50%)
TSLA   736.52 (+5.39%)
NVDA   577.55 (+2.10%)
BABA   249.97 (-1.10%)
CGC   35.56 (+0.71%)
GE   13.15 (+4.45%)
MU   91.85 (+4.10%)
NIO   51.49 (+4.85%)
AMD   86.54 (+2.12%)
T   29.45 (+0.93%)
F   12.24 (+5.34%)
ACB   11.58 (+3.30%)
DIS   197.18 (+0.05%)
BA   228.69 (+7.81%)
NFLX   551.82 (+1.04%)
BAC   36.34 (+2.31%)
S&P 500   3,926.63 (+1.17%)
DOW   31,974.10 (+1.38%)
QQQ   323.57 (+0.65%)
AAPL   124.79 (-0.85%)
MSFT   234.52 (+0.54%)
FB   264.56 (-0.49%)
GOOGL   2,081.20 (+1.02%)
AMZN   3,146.46 (-1.50%)
TSLA   736.52 (+5.39%)
NVDA   577.55 (+2.10%)
BABA   249.97 (-1.10%)
CGC   35.56 (+0.71%)
GE   13.15 (+4.45%)
MU   91.85 (+4.10%)
NIO   51.49 (+4.85%)
AMD   86.54 (+2.12%)
T   29.45 (+0.93%)
F   12.24 (+5.34%)
ACB   11.58 (+3.30%)
DIS   197.18 (+0.05%)
BA   228.69 (+7.81%)
NFLX   551.82 (+1.04%)
BAC   36.34 (+2.31%)
S&P 500   3,926.63 (+1.17%)
DOW   31,974.10 (+1.38%)
QQQ   323.57 (+0.65%)
AAPL   124.79 (-0.85%)
MSFT   234.52 (+0.54%)
FB   264.56 (-0.49%)
GOOGL   2,081.20 (+1.02%)
AMZN   3,146.46 (-1.50%)
TSLA   736.52 (+5.39%)
NVDA   577.55 (+2.10%)
BABA   249.97 (-1.10%)
CGC   35.56 (+0.71%)
GE   13.15 (+4.45%)
MU   91.85 (+4.10%)
NIO   51.49 (+4.85%)
AMD   86.54 (+2.12%)
T   29.45 (+0.93%)
F   12.24 (+5.34%)
ACB   11.58 (+3.30%)
DIS   197.18 (+0.05%)
BA   228.69 (+7.81%)
NFLX   551.82 (+1.04%)
BAC   36.34 (+2.31%)
S&P 500   3,926.63 (+1.17%)
DOW   31,974.10 (+1.38%)
QQQ   323.57 (+0.65%)
AAPL   124.79 (-0.85%)
MSFT   234.52 (+0.54%)
FB   264.56 (-0.49%)
GOOGL   2,081.20 (+1.02%)
AMZN   3,146.46 (-1.50%)
TSLA   736.52 (+5.39%)
NVDA   577.55 (+2.10%)
BABA   249.97 (-1.10%)
CGC   35.56 (+0.71%)
GE   13.15 (+4.45%)
MU   91.85 (+4.10%)
NIO   51.49 (+4.85%)
AMD   86.54 (+2.12%)
T   29.45 (+0.93%)
F   12.24 (+5.34%)
ACB   11.58 (+3.30%)
DIS   197.18 (+0.05%)
BA   228.69 (+7.81%)
NFLX   551.82 (+1.04%)
BAC   36.34 (+2.31%)
Log in
NASDAQ:ACOR

Acorda Therapeutics Short Interest Ratio and Short Volume

$6.23
+0.09 (+1.47 %)
(As of 02/24/2021 03:21 PM ET)
Add
Compare
Today's Range
$6.22
Now: $6.23
$6.79
50-Day Range
$3.91
MA: $6.61
$8.04
52-Week Range
$2.53
Now: $6.23
$9.84
Volume3,719 shs
Average Volume1.64 million shs
Market Capitalization$49.81 million
P/E Ratio1.13
Dividend YieldN/A
Beta0.75

Short Interest

Acorda Therapeutics (NASDAQ:ACOR) Short Interest Data

Current Short Volume:539,400 shares
Previous Short Volume:1,080,000 shares
Change Vs. Previous Month:-50.06%
Dollar Volume Sold Short:$3.99 million
Short Interest Ratio / Days to Cover:0.0
Last Record Date:January, 29 2021
Outstanding Shares:48,130,000 shares
Float Size:9,320,000 shares
Short Percent of Float:5.79%
Today's Trading Volume:3,719 shares
Average Trading Volume:1,642,264 shares
Today's Volume Vs. Average:-99.77%


Acorda Therapeutics (NASDAQ:ACOR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/2021539,400 shares $3.99 million -50.1%5.8%0.5 $7.40
1/15/20211,080,000 shares $7.45 million -56.8%11.6%0.9 $6.90
12/31/20202,610,000 shares $10.70 million -68.6%5.5%0.4 $4.10
12/15/20202,610,000 shares $10.54 million -68.6%5.5%0.4 $4.04
11/30/20208,320,000 shares $6.32 million +53.5%17.7%1.3 $0.76
11/15/20205,420,000 shares $3.63 million -25.1%11.5%0.9 $0.67
10/30/20207,240,000 shares $6.01 million -25.1%15.4%1.2 $0.83
10/15/20209,660,000 shares $8.40 million -23.3%20.5%1.7 $0.87
9/30/202012,600,000 shares $8.95 million +24.9%26.7%3.1 $0.71
9/15/202010,090,000 shares $6.26 million -8.3%21.4%4.9 $0.62
8/31/202011,000,000 shares $5.17 million +9.8%23.3%5.2 $0.47
8/14/202010,020,000 shares $5.31 million +2.0%21.2%4.2 $0.53
7/31/20209,820,000 shares $6.19 million +2.4%20.8%3.7 $0.63
7/15/20209,590,000 shares $6.04 million +5.2%20.3%3.9 $0.63
6/30/20209,120,000 shares $6.93 million -12.2%19.3%4.6 $0.76
6/15/202010,390,000 shares $7.48 million +23.8%22.0%5.4 $0.72
5/29/20208,390,000 shares $6.29 million -19.1%17.8%4.6 $0.75
5/15/202010,370,000 shares $7.78 million -26.9%22.0%6.4 $0.75
4/30/202014,190,000 shares $11.21 million +8.4%30.1%8.7 $0.79
4/15/202013,090,000 shares $9.69 million -1.5%27.8%8.3 $0.74
3/31/202013,290,000 shares $13.82 million -4.7%28.2%7.1 $1.04
3/13/202013,944,700 shares $14.92 million -0.8%29.6%12 $1.07
2/28/202014,060,000 shares $12.23 million -4.8%29.8%5.4 $0.87
2/14/202014,770,000 shares $15.80 million +1.3%31.3%5.6 $1.07
1/31/202014,580,000 shares $19.25 million +3.0%30.9%6 $1.32

Acorda Therapeutics (NASDAQ:ACOR) Short Interest FAQ

speech bubbles
speech bubbles











What is Acorda Therapeutics' current short interest?

Short interest is the volume of Acorda Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 29th, investors have sold 539,400 shares of ACOR short. 5.79% of Acorda Therapeutics' shares are currently sold short. View details.

What is a good short interest percentage for Acorda Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.79% of Acorda Therapeutics' floating shares are currently sold short.

Is Acorda Therapeutics' short interest increasing or decreasing?

Acorda Therapeutics saw a decline in short interest in January. As of January 29th, there was short interest totaling 539,400 shares, a decline of 50.1% from the previous total of 1,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acorda Therapeutics' float size?

Acorda Therapeutics currently has issued a total of 7,995,000 shares. Some of Acorda Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acorda Therapeutics currently has a public float of 9,320,000 shares.

How does Acorda Therapeutics' short interest compare to its competitors?

5.79% of Acorda Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Acorda Therapeutics: Amgen Inc. (1.31%), Gilead Sciences, Inc. (1.73%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals, Inc. (1.90%), Biogen Inc. (2.41%), Alexion Pharmaceuticals, Inc. (2.00%), Seagen Inc. (0.00%), Exact Sciences Co. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), and Incyte Co. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Acorda Therapeutics stock?

Short selling ACOR is an investing strategy that aims to generate trading profit from Acorda Therapeutics as its price is falling. Acorda Therapeutics' stock is trading up $0.09 today. To short Acorda Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Acorda Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acorda Therapeutics?

A short squeeze for Acorda Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACOR, which in turn drives the price of the stock up even further.

How often is Acorda Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACOR, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.